Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
A 2023 healthcare access survey found 68% of patients preferred telehealth initiation for weight-management medications, citing reduced visit burden while maintaining clinical oversight
Still, while not the cheapest option on the market, the flexible dosing, stabilized format, and third-party testing justify the higher price
The resulting supernatant was then transferred to a glass vial for LCMS analysis
Zepbound was approved by the Food and Drug Administration in November 2023 for weight loss in adults with obesity or who are overweight with at least one related condition like type 2 diabetes, high cholesterol, or high blood pressure)
Healthcare professionals should consult applicable FDA guidance, professional society recommendations, and institutional policies when managing individual patients.
The cost is dependent on the IV selected and are all clearly listed in our pricing tables
US$ 21.29
US$ 21.57
US$ 24.67
US$ 23.22
US$ 26.33
US$ 24.36
US$ 26.75
US$ 25.25
